SOHO 2024: Focus on CLL
Advertisement
Cytogenic anomaly screening should be performed in every patient with CLL.
A study finds that CD200 is an effective diagnostic marker in atypical chronic lymphocytic leukemia.
For patients with B-cell CLL, a simple method is effective at identifying patients eligible for personalized therapies.
Oral target inhibitors are a viable treatment option for CLL patients with serve renal dysfunction.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.